Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Vet Intern Med ; 28(5): 1541-5, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25066405

RESUMO

BACKGROUND: Measurement of basal serum or plasma cortisol concentration is used as a screening test for hypoadrenocorticism in dogs, but is not well characterized. OBJECTIVES: To evaluate the sensitivity and specificity of basal serum cortisol to detect hypoadrenocorticism in a population of dogs with a clinical suspicion of hypoadrenocorticism. ANIMALS: Four hundred and fifty dogs with nonadrenal gland illness and 14 dogs with naturally occurring hypoadrenocorticism were included. METHODS: Retrospective case-control study. The records of all dogs having had an ACTH stimulation test performed between January 2005 and September 2011 at the University of Bristol were reviewed. Dogs were included if the test was performed as a screening for hypoadrenocorticism. The sensitivity and specificity of basal serum cortisol concentration to detect dogs with hypoadrenocorticism were calculated using 2 cut-offs and compared to the gold standard ACTH stimulation test. RESULTS: Using a cut-off of ≤2 µg/dL (≤55 nmol/L), the sensitivity and specificity of basal cortisol to detect hypoadrenocorticism were 100% and 63.3%, respectively, whereas for a cut-off of ≤1 µg/dL (≤28 nmol/L), the sensitivity and specificity were 85.7% and 91.8%, respectively. CONCLUSIONS AND CLINICAL IMPORTANCE: Measurement of basal serum cortisol is useful as a screening test for hypoadrenocorticism in dogs using a cut-off of ≤2 µg/dL (≤55 nmol/L), and the disease is unlikely with a basal serum cortisol >2 µg/dL (>55 nmol/L). A basal serum cortisol ≤2 µg/dL (≤55 nmol/L) cannot be used to diagnose hypoadrenocorticism, and an ACTH stimulation test should be performed in these cases.


Assuntos
Insuficiência Adrenal/veterinária , Doenças do Cão/sangue , Hidrocortisona/sangue , Insuficiência Adrenal/sangue , Insuficiência Adrenal/diagnóstico , Animais , Estudos de Casos e Controles , Doenças do Cão/diagnóstico , Cães , Estudos Retrospectivos
2.
Vet Comp Oncol ; 7(1): 1-14, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19222826

RESUMO

Cutaneous epitheliotropic T-cell lymphoma in the dog is a rare neoplastic condition with unknown aetiology. The dermatitis is characterized by infiltration of neoplastic T lymphocytes with a specific tropism for the epidermis and the adnexal structures. The different clinical and histological forms (mycosis fungoides, pagetoid reticulosis and Sézary syndrome) are reviewed. The disease in the dog resembles the human syndrome, but in 80% of the canine cases, neoplastic cells are CD4(-)/CD8(+) versus CD4(+)/CD8(-) in 90% of the human patients. Prognosis is poor with a survival time from few months to 2 years. Treatments frequently have a low efficacy. New protocols using lomustine may improve the poor prognosis of the disease.


Assuntos
Doenças do Cão/patologia , Linfoma Cutâneo de Células T/veterinária , Neoplasias Cutâneas/veterinária , Animais , Antineoplásicos Alquilantes/uso terapêutico , Doenças do Cão/tratamento farmacológico , Cães , Epiderme/patologia , Feminino , Humanos , Lomustina/uso terapêutico , Linfoma Cutâneo de Células T/tratamento farmacológico , Linfoma Cutâneo de Células T/patologia , Masculino , Prognóstico , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/patologia , Linfócitos T/patologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA